Benefit of a Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The purpose of this study is to evaluate the impact of a collaborative approach (geriatric care involving the collaboration with a clinical pharmacist) to optimize the prescription of medicines for elderly inpatients.
| Condition | Intervention | Phase |
|---|---|---|
|
Frail Elderly Inpatient |
Behavioral: Pharmaceutical care |
Phase 4 |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label Primary Purpose: Educational/Counseling/Training |
| Official Title: | Collaborative Approach to Improve the Quality of Medicines Use in Elderly Inpatients - Randomized Controlled Trial |
- Appropriateness of prescribing (using the Medication Appropriateness Index, the Beers criteria, and the ACOVE criteria of underuse) on admission, at discharge, and 3 months post-discharge
- Polymedication on admission, at discharge, and 1,3,12 months after discharge
- Mortality, readmission to hospital and visit to the emergency department 1,3,12 months after discharge
- Satisfaction with information received on medicines
| Estimated Enrollment: | 180 |
| Study Start Date: | November 2003 |
| Estimated Study Completion Date: | June 2005 |
Widespread evidence reveals frequent inadequate use of medicines in elderly patients. This includes inappropriate prescribing (overuse, underuse, misuse) that can lead to adverse drug events and drug-related admissions to hospital. In addition, when a patient is transferred from acute care settings to ambulatory care settings, discrepancies in medicines used often occur and can be hazardous.
Despite this, only limited data exist on the effectiveness of optimization strategies targeted at frail elderly inpatients.
Comparison: elderly inpatients receiving geriatric evaluation and management (GEM) care versus elderly inpatients receiving pharmaceutical care in addition to GEM care.
Eligibility| Ages Eligible for Study: | 70 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Patient admitted on the acute geriatric unit of the university teaching hospital Mont-Godinne, Belgium
Exclusion Criteria:
- a terminal illness and life expectancy of less than 3 month
- expected length of stay of 2 days or less
- transfer from another unit where the patient had already been cared for by a GEM team
- refusal to participate
- inclusion during previous admission
- no time for the clinical pharmacist to compound the abstracted chart within 3 days of admission
Contacts and Locations| Belgium | |
| Université catholique de Louvain | |
| Brussels, Belgium, 1200 | |
| Principal Investigator: | Anne Spinewine, MSc | Université Catholique de Louvain |
| Study Chair: | Christian Swine, MD | Université Catholique de Louvain |
| Study Director: | Paul M Tulkens, PhD | Université Catholique de Louvain |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00279656 History of Changes |
| Other Study ID Numbers: | om050-40/2003 |
| Study First Received: | January 17, 2006 |
| Last Updated: | January 17, 2006 |
| Health Authority: | Belgium: Institutional Review Board |
Keywords provided by Université Catholique de Louvain:
|
Frail elderly Pharmaceutical services Drug therapy |
Geriatrics Randomized controlled trial Hospitals, teaching |
ClinicalTrials.gov processed this record on May 16, 2013